Glucagon
Also known as: GlucaGen, Baqsimi
Key Facts: Glucagon
- Category
- Hormonal
- FDA Status
- FDA Approved
- Clinical Status
- FDA Approved - Hypoglycemia and diagnostic
- Administration
- Injection, intranasal, or auto-injector
- Typical Dose
- Limited community data available
- Frequency
- See research protocols
- Evidence Level
- FDA Approved
- Duration
- Single dose emergency use
What to Expect
A counter-regulatory hormone to insulin. FDA approved for severe hypoglycemia treatment and diagnostic procedures.
Mechanism of Action
Glucagon binds to glucagon receptors in the liver, activating glycogenolysis and gluconeogenesis to raise blood glucose. Also relaxes smooth muscle in the GI tract for diagnostic imaging.
Research Summary
Life-saving treatment for severe hypoglycemia since the 1960s. Newer formulations include nasal spray (Baqsimi) and stable liquid (Gvoke). Essential emergency medication for insulin users.
Dosing Information
Typical Dosingⓘ
Community experience
Limited community data available
See research dosing
See research protocols
Research Dosingⓘ
Scientific studies
Emergency dosing
Doses from Studies
1 mg IM/SC/IV for hypoglycemia
3 mg intranasal (Baqsimi)
Duration
Single dose emergency use
Administration
Injection, intranasal, or auto-injector
Timing & Administration
Best Time to Take
Morning
Follow specific protocol
Food Recommendation
Take on empty stomach
Why This Timing?
Metabolic peptides often work best when taken in the morning to support daytime energy expenditure.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Nausea (up to 35%)
- ●Vomiting
- ●Headache
- ●Hypertension
- ●Tachycardia
- ●Allergic reactions
- ●Rebound hypoglycemia
- ●CONTRAINDICATED with pheochromocytoma
- ●FDA approved
References
Related Peptides
Peptides commonly compared with Glucagon or used in similar applications.
MOTS-c
PreclinicalA mitochondria-derived peptide that regulates metabolic homeostasis. Discovered in 2015, it's being studied for its effects on insulin sensitivity, exercise capacity, and aging.
HormonalOxytocin
FDAA naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.
HormonalGonadorelin
FDAA synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.
HormonalLeuprolide
FDAA GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
HormonalDesmopressin
FDAA synthetic analog of vasopressin (ADH) used for diabetes insipidus, bedwetting, and bleeding disorders. Does not cause vasoconstriction like natural vasopressin.
HormonalOctreotide
FDAA synthetic somatostatin analog that inhibits multiple hormones. Used for acromegaly, carcinoid tumors, and various GI conditions.
HormonalWant updates on Glucagon research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.